{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:55:27Z","timestamp":1789761327666,"version":"4.0.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1A2C2008050"],"award-info":[{"award-number":["2019R1A2C2008050"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI19C1330"],"award-info":[{"award-number":["HI19C1330"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University | Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2021-0208"],"award-info":[{"award-number":["6-2021-0208"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University | Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2020-0208"],"award-info":[{"award-number":["6-2020-0208"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Severance Hospital Research Fund for Clinical Excellency"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genomic and transcriptomic profiling has enhanced the diagnostic and treatment options for many cancers. However, the molecular characteristics of parathyroid cancer remain largely unexplored, thereby limiting the development of new therapeutic interventions. Herein, we conducted genomic and transcriptomic sequencing of 50 parathyroid tissues (12 carcinomas, 28 adenomas, and 10 normal tissues) to investigate the intrinsic and comparative molecular features of parathyroid carcinoma. We confirmed multiple two-hit mutation patterns in cell division cycle 73 (<jats:italic>CDC73<\/jats:italic>) that converged to biallelic inactivation, calling into question the presence of a second hit in other genes. In addition, allele-specific repression of <jats:italic>CDC73<\/jats:italic> in copies with germline-truncating variants suggested selective pressure prior to tumorigenesis. Transcriptomic analysis identified upregulation of the expression of E2F targets, <jats:italic>KRAS<\/jats:italic> and TNF-alpha signaling, and epithelial-mesenchymal transition pathways in carcinomas compared to adenomas and normal tissues. A molecular classification model based on carcinoma-specific genes clearly separated carcinomas from adenomas and normal tissues, the clinical utility of which was demonstrated in two patients with uncertain malignant potential. A deeper analysis of gene expression and functional prediction suggested that Wilms tumor 1 (<jats:italic>WT1<\/jats:italic>) is a potential biomarker for <jats:italic>CDC73<\/jats:italic>-mutant parathyroid carcinoma, which was further validated through immunohistochemistry. Overall, our study revealed the genomic and transcriptomic profiles of parathyroid carcinoma and may help direct future precision diagnostic and therapeutic improvements.<\/jats:p>","DOI":"10.1038\/s12276-023-00968-4","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T01:02:02Z","timestamp":1682902922000},"page":"886-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma"],"prefix":"10.1038","volume":"55","author":[{"given":"Se-Young","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongsoo","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kyum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5356-0827","authenticated-orcid":false,"given":"Sangwoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,1]]},"reference":[{"key":"968_CR1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","volume":"86","author":"E Shane","year":"2001","unstructured":"Shane, E. Parathyroid carcinoma. J. Clin. Endocrinol. Metab. 86, 485\u2013493 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"968_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.pap.0000151319.42376.d4","volume":"12","author":"RA DeLellis","year":"2005","unstructured":"DeLellis, R. A. Parathyroid carcinoma: an overview. Adv. Anat. Pathol. 12, 53\u201361 (2005).","journal-title":"Adv. Anat. Pathol."},{"key":"968_CR3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1586\/17446651.3.3.377","volume":"3","author":"F Cetani","year":"2008","unstructured":"Cetani, F. et al. HRPT2 gene analysis and the diagnosis of parathyroid carcinoma. Expert Rev. Endocrinol. Metab. 3, 377\u2013389 (2008).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"968_CR4","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1359\/jbmr.081018","volume":"23","author":"C Marcocci","year":"2008","unstructured":"Marcocci, C. et al. Parathyroid carcinoma. J. Bone Miner. Res. 23, 1869\u20131880 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"968_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1200\/JOP.19.00540","volume":"17","author":"AL Fingeret","year":"2021","unstructured":"Fingeret, A. L. Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol. Pract. 17, 17\u201321 (2021).","journal-title":"JCO Oncol. Pract."},{"key":"968_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","volume":"33","author":"LA Erickson","year":"2022","unstructured":"Erickson, L. A., Mete, O., Juhlin, C. C., Perren, A. & Gill, A. J. Overview of the 2022 WHO classification of parathyroid tumors. Endocr. Pathol. 33, 64\u201389 (2022).","journal-title":"Endocr. Pathol."},{"key":"968_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.humpath.2020.07.008","volume":"110","author":"MD Williams","year":"2021","unstructured":"Williams, M. D. et al. Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum. Pathol. 110, 73\u201382 (2021).","journal-title":"Hum. Pathol."},{"key":"968_CR8","doi-asserted-by":"crossref","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","volume":"2","author":"C Pandya","year":"2017","unstructured":"Pandya, C. et al. Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight 2, e92061 (2017).","journal-title":"JCI Insight"},{"key":"968_CR9","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck, T. M. et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N. Engl. J. Med. 349, 1722\u20131729 (2003).","journal-title":"N. Engl. J. Med."},{"key":"968_CR10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1530\/EC-13-0046","volume":"2","author":"F Cetani","year":"2013","unstructured":"Cetani, F. et al. CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. Endocr. Connect 2, 186\u2013195 (2013).","journal-title":"Endocr. Connect"},{"key":"968_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2217\/ije.14.2","volume":"1","author":"WF Simonds","year":"2014","unstructured":"Simonds, W. F. Parathyroid cancer and the CDC73 tumor suppressor gene. Int. J. Endocr. Oncol. 1, 59\u201369 (2014).","journal-title":"Int. J. Endocr. Oncol."},{"key":"968_CR12","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1210\/js.2018-00043","volume":"3","author":"CN Clarke","year":"2019","unstructured":"Clarke, C. N. et al. Comprehensive genomic characterization of parathyroid cancer identifies novel candidate driver mutations and core pathways. J. Endocr. Soc. 3, 544\u2013559 (2019).","journal-title":"J. Endocr. Soc."},{"key":"968_CR13","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1002\/ijc.33166","volume":"147","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. The genomic profile of parathyroid carcinoma based on whole-genome sequencing. Int. J. Cancer 147, 2446\u20132457 (2020).","journal-title":"Int. J. Cancer"},{"key":"968_CR14","unstructured":"Ricardo V Lloyd, R. Y. O, G\u00fcnter Kl\u00f6ppel, Juan Rosai WHO Classification of Tumours of Endocrine Organs (International Agency for Research on Cancer (IARC), 2017)."},{"key":"968_CR15","doi-asserted-by":"publisher","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv https:\/\/doi.org\/10.48550\/arXiv.1303.3997 (2013).","DOI":"10.48550\/arXiv.1303.3997"},{"key":"968_CR16","unstructured":"Van der Auwera, G. A. & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, Incorporated, 2020)."},{"key":"968_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"968_CR18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"968_CR19","doi-asserted-by":"crossref","first-page":"bbab186","DOI":"10.1093\/bib\/bbab186","volume":"22","author":"M Diossy","year":"2021","unstructured":"Diossy, M. et al. Strand orientation bias detector to determine the probability of FFPE sequencing artifacts. Brief. Bioinform. 22, bbab186 (2021).","journal-title":"Brief. Bioinform."},{"key":"968_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"968_CR21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda, A., Lin, D. C., Assenov, Y., Plass, C. & Koeffler, H. P. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 28, 1747\u20131756 (2018).","journal-title":"Genome Res"},{"key":"968_CR22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","volume":"176","author":"M Petljak","year":"2019","unstructured":"Petljak, M. et al. Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis. Cell 176, 1282\u20131294.e20 (2019).","journal-title":"Cell"},{"key":"968_CR23","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinform. 11, 367 (2010).","journal-title":"BMC Bioinform."},{"key":"968_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"968_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/s13029-016-0060-z","volume":"11","author":"M Riester","year":"2016","unstructured":"Riester, M. et al. PureCN: copy number calling and SNV classification using targeted short read sequencing. Source Code Biol. Med 11, 13 (2016).","journal-title":"Source Code Biol. Med"},{"key":"968_CR26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"968_CR27","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"968_CR28","doi-asserted-by":"publisher","unstructured":"McDermaid, A., Monier, B., Zhao, J. & Ma, Q. ViDGER: An R package for integrative interpretation of differential gene expression results of RNA-seq data. bioRxiv https:\/\/doi.org\/10.1101\/268896 (2018).","DOI":"10.1101\/268896"},{"key":"968_CR29","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"968_CR30","doi-asserted-by":"crossref","first-page":"e75449","DOI":"10.1371\/journal.pone.0075449","volume":"8","author":"GJ Kim","year":"2013","unstructured":"Kim, G. J., Kim, H. & Park, Y. N. Increased expression of Yes-associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma. PLoS One 8, e75449\u2013e75449 (2013).","journal-title":"PLoS One"},{"key":"968_CR31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","volume":"31","author":"PJ Newey","year":"2010","unstructured":"Newey, P. J., Bowl, M. R., Cranston, T. & Thakker, R. V. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum. Mutat. 31, 295\u2013307 (2010).","journal-title":"Hum. Mutat."},{"key":"968_CR32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/HJH.0000000000002250","volume":"38","author":"TM Seccia","year":"2020","unstructured":"Seccia, T. M. et al. Atrial fibrillation as presenting sign of primary aldosteronism: results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (PAPPHY) study. J. Hypertens. 38, 332\u2013339 (2020).","journal-title":"J. Hypertens."},{"key":"968_CR33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","volume":"6","author":"K Ellrott","year":"2018","unstructured":"Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271\u2013281.e7 (2018).","journal-title":"Cell Syst."},{"key":"968_CR34","doi-asserted-by":"crossref","first-page":"682017","DOI":"10.3389\/fonc.2021.682017","volume":"11","author":"H Yuan","year":"2021","unstructured":"Yuan, H. et al. Characteristics of pan-cancer patients with ultrahigh tumor mutation burden. Front. Oncol. 11, 682017 (2021).","journal-title":"Front. Oncol."},{"key":"968_CR35","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1074\/jbc.M111.325647","volume":"287","author":"CG Amrich","year":"2012","unstructured":"Amrich, C. G. et al. Cdc73 subunit of Paf1 complex contains C-terminal Ras-like domain that promotes association of Paf1 complex with chromatin. J. Biol. Chem. 287, 10863\u201310875 (2012).","journal-title":"J. Biol. Chem."},{"key":"968_CR36","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/celldisc.2015.34","volume":"1","author":"P Herr","year":"2015","unstructured":"Herr, P. et al. A genome-wide IR-induced RAD51 foci RNAi screen identifies CDC73 involved in chromatin remodeling for DNA repair. Cell Disco. 1, 15034 (2015).","journal-title":"Cell Disco."},{"key":"968_CR37","doi-asserted-by":"crossref","first-page":"e1007170","DOI":"10.1371\/journal.pgen.1007170","volume":"14","author":"RV Nene","year":"2018","unstructured":"Nene, R. V. et al. Cdc73 suppresses genome instability by mediating telomere homeostasis. PLoS Genet 14, e1007170 (2018).","journal-title":"PLoS Genet"},{"key":"968_CR38","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"968_CR39","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan, K. et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47, 1067\u20131072 (2015).","journal-title":"Nat. Genet."},{"key":"968_CR40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14568-7","volume":"11","author":"CB Driscoll","year":"2020","unstructured":"Driscoll, C. B. et al. APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy. Nat. Commun. 11, 790 (2020).","journal-title":"Nat. Commun."},{"key":"968_CR41","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41388-018-0245-9","volume":"37","author":"S Wang","year":"2018","unstructured":"Wang, S., Jia, M., He, Z. & Liu, X. S. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer. Oncogene 37, 3924\u20133936 (2018).","journal-title":"Oncogene"},{"key":"968_CR42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.tips.2022.02.007","volume":"43","author":"MJ Grillo","year":"2022","unstructured":"Grillo, M. J., Jones, K. F. M., Carpenter, M. A., Harris, R. S. & Harki, D. A. The current toolbox for APOBEC drug discovery. Trends Pharmacol. Sci. 43, 362\u2013377 (2022).","journal-title":"Trends Pharmacol. Sci."},{"key":"968_CR43","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1128\/MCB.19.5.3704","volume":"19","author":"C Blattner","year":"1999","unstructured":"Blattner, C., Sparks, A. & Lane, D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell. Biol. 19, 3704\u20133713 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"968_CR44","first-page":"1","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu, V. S. et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16, 1\u201315 (2014).","journal-title":"Nat. Cell Biol."},{"key":"968_CR45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fonc.2020.00499","volume":"10","author":"I Georgakopoulos-Soares","year":"2020","unstructured":"Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V. & Zaravinos, A. EMT factors and metabolic pathways in cancer. Front. Oncol. 10, 499 (2020).","journal-title":"Front. Oncol."},{"key":"968_CR46","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41416-021-01385-y","volume":"124","author":"D Jia","year":"2021","unstructured":"Jia, D. et al. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer. Br. J. Cancer 124, 1902\u20131911 (2021).","journal-title":"Br. J. Cancer"},{"key":"968_CR47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/jcm10010060","volume":"10","author":"S Pasani","year":"2020","unstructured":"Pasani, S., Sahoo, S. & Jolly, M. K. Hybrid E\/M phenotype(s) and stemness: a mechanistic connection embedded in network topology. J. Clin. Med. 10, 60 (2020).","journal-title":"J. Clin. Med."},{"key":"968_CR48","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1073\/pnas.1812876116","volume":"116","author":"C Kroger","year":"2019","unstructured":"Kroger, C. et al. Acquisition of a hybrid E\/M state is essential for tumorigenicity of basal breast cancer cells. Proc. Natl Acad. Sci. USA 116, 7353\u20137362 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"968_CR49","doi-asserted-by":"crossref","first-page":"e1008213","DOI":"10.1371\/journal.pgen.1008213","volume":"15","author":"CM Dooley","year":"2019","unstructured":"Dooley, C. M. et al. The gene regulatory basis of genetic compensation during neural crest induction. PLoS Genet 15, e1008213 (2019).","journal-title":"PLoS Genet"},{"key":"968_CR50","doi-asserted-by":"crossref","first-page":"54616","DOI":"10.18632\/oncotarget.10520","volume":"7","author":"HJ Jin","year":"2016","unstructured":"Jin, H. J., Jung, S., DebRoy, A. R. & Davuluri, R. V. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer. Oncotarget 7, 54616\u201354626 (2016).","journal-title":"Oncotarget"},{"key":"968_CR51","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1074\/jbc.M113.483255","volume":"289","author":"MI Rather","year":"2014","unstructured":"Rather, M. I., Swamy, S., Gopinath, K. S. & Kumar, A. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics. J. Biol. Chem. 289, 968\u2013976 (2014).","journal-title":"J. Biol. Chem."},{"key":"968_CR52","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ejca.2007.04.008","volume":"43","author":"A Coosemans","year":"2007","unstructured":"Coosemans, A. et al. Upregulation of Wilms\u2019 tumour gene 1 (WT1) in uterine sarcomas. Eur. J. Cancer 43, 1630\u20131637 (2007).","journal-title":"Eur. J. Cancer"},{"key":"968_CR53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejca.2008.01.008","volume":"44","author":"T Sera","year":"2008","unstructured":"Sera, T. et al. Wilms\u2019 tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis. Eur. J. Cancer 44, 600\u2013608 (2008).","journal-title":"Eur. J. Cancer"},{"key":"968_CR54","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/cncr.21861","volume":"106","author":"T Sotobori","year":"2006","unstructured":"Sotobori, T. et al. Prognostic significance of Wilms tumor gene (WT1) mRNA expression in soft tissue sarcoma. Cancer 106, 2233\u20132240 (2006).","journal-title":"Cancer"},{"key":"968_CR55","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gr.133744.111","volume":"22","author":"S Anders","year":"2012","unstructured":"Anders, S., Reyes, A. & Huber, W. Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008\u20132017 (2012).","journal-title":"Genome Res."},{"key":"968_CR56","doi-asserted-by":"crossref","first-page":"e48770","DOI":"10.1371\/journal.pone.0048770","volume":"7","author":"T Sen","year":"2012","unstructured":"Sen, T. et al. OGDHL is a modifier of AKT-dependent signaling and NF-kappaB function. PLoS One 7, e48770 (2012).","journal-title":"PLoS One"},{"key":"968_CR57","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.32825","volume":"146","author":"X Guo","year":"2020","unstructured":"Guo, X. et al. Discovery of rare coding variants in OGDHL and BRCA2 in relation to breast cancer risk in Chinese women. Int. J. Cancer 146, 2175\u20132181 (2020).","journal-title":"Int. J. Cancer"},{"key":"968_CR58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1530\/ERC-18-0480","volume":"26","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Profiling analysis of long non-coding RNA and mRNA in parathyroid carcinoma. Endocr. Relat. Cancer 26, 163\u2013176 (2019).","journal-title":"Endocr. Relat. Cancer"},{"key":"968_CR59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/ERC-20-0450","volume":"28","author":"V Condello","year":"2021","unstructured":"Condello, V. et al. Gene expression profile in metastatic and non-metastatic parathyroid carcinoma. Endocr. Relat. Cancer 28, 111\u2013134 (2021).","journal-title":"Endocr. Relat. Cancer"},{"key":"968_CR60","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.1073\/pnas.0710725105","volume":"105","author":"L Lin","year":"2008","unstructured":"Lin, L., Zhang, J. H., Panicker, L. M. & Simonds, W. F. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc. Natl Acad. Sci. USA 105, 17420\u201317425 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"968_CR61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1541-7786.MCR-11-0519","volume":"10","author":"MJ Tan","year":"2012","unstructured":"Tan, M. J., Teo, Z., Sng, M. K., Zhu, P. & Tan, N. S. Emerging roles of angiopoietin-like 4 in human cancer. Mol. Cancer Res. 10, 677\u2013688 (2012).","journal-title":"Mol. Cancer Res."},{"key":"968_CR62","volume":"9","author":"ZR Lin","year":"2018","unstructured":"Lin, Z. R., Wang, M. Y., He, S. Y., Cai, Z. M. & Huang, W. R. TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer. Cell Death Dis. 9, 72 (2018).","journal-title":"Cell Death Dis."},{"key":"968_CR63","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08480-y","volume":"10","author":"T Daubon","year":"2019","unstructured":"Daubon, T. et al. Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nat. Commun. 10, 1146 (2019).","journal-title":"Nat. Commun."},{"key":"968_CR64","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","volume":"51","author":"J Gogusev","year":"1997","unstructured":"Gogusev, J. et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int. 51, 328\u2013336 (1997).","journal-title":"Kidney Int."},{"key":"968_CR65","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1634\/theoncologist.2009-0185","volume":"15","author":"MA Adam","year":"2010","unstructured":"Adam, M. A., Untch, B. R. & Olson, J. A. Jr Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics. Oncologist 15, 61\u201372 (2010).","journal-title":"Oncologist"},{"key":"968_CR66","first-page":"134","volume":"38","author":"J Yang","year":"2017","unstructured":"Yang, J. et al. Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect. Carcinogenesis 38, 134\u2013143 (2017).","journal-title":"Carcinogenesis"},{"key":"968_CR67","doi-asserted-by":"crossref","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu, W. et al. Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J. Clin. Endocrinol. Metab. 100, E360\u2013E364 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"968_CR68","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/js.2018-00315","volume":"3","author":"J Costa-Guda","year":"2019","unstructured":"Costa-Guda, J. Commentary: Next-generation sequence analysis of parathyroid carcinoma. J. Endocr. Soc. 3, 560\u2013562 (2019).","journal-title":"J. Endocr. Soc."},{"key":"968_CR69","doi-asserted-by":"crossref","first-page":"834362","DOI":"10.3389\/fendo.2022.834362","volume":"13","author":"F Marini","year":"2022","unstructured":"Marini, F. et al. Genetics and epigenetics of parathyroid carcinoma. Front. Endocrinol. (Lausanne) 13, 834362 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"968_CR70","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s12020-013-9903-4","volume":"44","author":"J Costa-Guda","year":"2013","unstructured":"Costa-Guda, J. et al. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins. Endocrine 44, 489\u2013495 (2013).","journal-title":"Endocrine"},{"key":"968_CR71","volume":"5","author":"XW Qi","year":"2015","unstructured":"Qi, X. W. et al. Wilms\u2019 tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis. Sci. Rep. 5, 8924 (2015).","journal-title":"Sci. Rep."},{"key":"968_CR72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/jc.2008-1740","volume":"94","author":"VM Howell","year":"2009","unstructured":"Howell, V. M. et al. Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J. Clin. Endocrinol. Metab. 94, 434\u2013441 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"968_CR73","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-016-9426-7","volume":"27","author":"N Kumari","year":"2016","unstructured":"Kumari, N., Chaudhary, N., Pradhan, R., Agarwal, A. & Krishnani, N. Role of histological criteria and immunohistochemical markers in predicting risk of malignancy in parathyroid neoplasms. Endocr. Pathol. 27, 87\u201396 (2016).","journal-title":"Endocr. Pathol."},{"key":"968_CR74","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-017-1705-x","volume":"18","author":"F Zare","year":"2017","unstructured":"Zare, F., Dow, M., Monteleone, N., Hosny, A. & Nabavi, S. An evaluation of copy number variation detection tools for cancer using whole exome sequencing data. BMC Bioinform. 18, 286 (2017).","journal-title":"BMC Bioinform."},{"key":"968_CR75","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jmoldx.2017.07.004","volume":"19","author":"J Kerkhof","year":"2017","unstructured":"Kerkhof, J. et al. Clinical validation of copy number variant detection from targeted next-generation sequencing panels. J. Mol. Diagn. 19, 905\u2013920 (2017).","journal-title":"J. Mol. Diagn."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-00968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-00968-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-00968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:32:11Z","timestamp":1685694731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-00968-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,1]]},"references-count":75,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["968"],"URL":"https:\/\/doi.org\/10.1038\/s12276-023-00968-4","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,1]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}